Gene · 6491
Papers1,377
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,377
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer. | Int J Radiat Oncol Biol Phys | 2026 | 41015093 | PubTator, text mining | PubMed |
| H3K18la Facilitates TRA2A-Mediated Alternative Splicing of STIL, Suppressing Ferroptosis and Cisplatin Treatment Sensitivity in Ovarian Cancer. | Cancer Res Treat | 2026 | 40907573 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing in Recurrent Pregnancy Loss: Current Evidence and Future Directions in Saudi Arabia. | Med Arch | 2025 | 41768206 | PubTator, text mining | PubMed |
| Expanding the mutational spectrum of congenital microcephaly in Pakistani families. | Front Genet | 2025 | 41555927 | PubTator, text mining | PubMed |
| Clinical significance of CD155 expression and correlation with immune cell infiltration in triple-negative breast cancer. | Transl Cancer Res | 2025 | 41234834 | PubTator, text mining | PubMed |
| Safety Integrity Level (SIL) assessment process for WSN using multi-QoS metrics. | MethodsX | 2025 | 41146966 | PubTator, text mining | PubMed |
| Decoding Cervical Cancer Biomarkers: An Integrated Framework of Bioinformatics, Machine Learning, and Experimental Confirmation. | Cancer Invest | 2025 | 41123057 | PubTator, text mining | PubMed |
| Cell-type-specific cis-eQTLs in pancreatic cell types identify novel risk genes for type 2 diabetes. | Brief Bioinform | 2025 | 41066696 | PubTator, text mining | PubMed |
| The cost-analysis of Team-Based Learning versus small group interactive learning in undergraduate medical education. | BMC Med Educ | 2025 | 41039339 | PubTator, text mining | PubMed |
| Genetic variants underlying congenital Zika syndrome and severe microcephaly: a systematic review and meta-analysis. | Virusdisease | 2025 | 41018223 | PubTator, text mining | PubMed |
| Interpretable Machine Learning for Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Using the Baseline Clinical and Pathological Characteristics. | Cancer Med | 2025 | 40917012 | PubTator, text mining | PubMed |
| Characteristics and management of mechanically ventilated patients in South Korea compared with other high-income Asian countries and regions. | Acute Crit Care | 2025 | 40903405 | PubTator, text mining | PubMed |
| Breast cancer as the first primary malignancy: clinical pathological characteristics of common cancer combinations. | Discov Oncol | 2025 | 40848178 | PubTator, text mining | PubMed |
| Pathway Analysis Interpretation in the Multi-Omic Era. | BioTech (Basel) | 2025 | 40843781 | PubTator, text mining | PubMed |
| Dysregulated SASS6 expression promotes increased ciliogenesis and cell invasion phenotypes. | Life Sci Alliance | 2025 | 40825584 | PubTator, text mining | PubMed |
| Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma. | J Thorac Dis | 2025 | 40809245 | PubTator, text mining | PubMed |
| Centriole Duplication at the Crossroads of Cell Cycle Control and Oncogenesis. | Cells | 2025 | 40710347 | PubTator, text mining | PubMed |
| Whole exome-based variant profiling and functional network characterization in neural tube defects. | Childs Nerv Syst | 2025 | 40613906 | PubTator, text mining | PubMed |
| First Analysis of the Incidence of Serous Tubal Intraepithelial Carcinoma (STIC) in Germany - Evaluation of the Cancer Registry of the Federal State of Rhineland-Palatinate from 2016 to 2023. | Geburtshilfe Frauenheilkd | 2025 | 40386497 | PubTator, text mining | PubMed |
| WDR62 affects the progression of ovarian cancer by regulating the cell cycle. | Hereditas | 2025 | 40369663 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6491/papers?page=2